We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The war in Ukraine and rising inflation have weighed on investor sentiment lately. As the Federal Reserve is expected to raise rates aggressively to tame inflation, many investors have sought refuge in safer companies that could generate consistent revenues amid rising uncertainties.
Healthcare, which is seen as a defensive sector, has gained from investors’ rush to safety over the past month. Despite the recent outperformance, the sector remains attractively valued as it had lagged the broader indexes over the past two years.
The Health Care Select Sector SPDR Fund (XLV - Free Report) is the most popular product in the space with about $39 billion in assets. The Vanguard Health Care ETF (VHT - Free Report) and iShares U.S. Healthcare ETF (IYH - Free Report) are also worth a look.
United Health (UNH - Free Report) , Johnson & Johnson (JNJ - Free Report) , AbbVie (ABBV), Pfizer (PFE - Free Report) and Eli Lilly (LLY - Free Report) are among the top holdings in these ETFs. To learn more, please watch the short video above.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Healthcare ETFs Outperform Amid Rising Uncertainties
The war in Ukraine and rising inflation have weighed on investor sentiment lately. As the Federal Reserve is expected to raise rates aggressively to tame inflation, many investors have sought refuge in safer companies that could generate consistent revenues amid rising uncertainties.
Healthcare, which is seen as a defensive sector, has gained from investors’ rush to safety over the past month. Despite the recent outperformance, the sector remains attractively valued as it had lagged the broader indexes over the past two years.
The Health Care Select Sector SPDR Fund (XLV - Free Report) is the most popular product in the space with about $39 billion in assets. The Vanguard Health Care ETF (VHT - Free Report) and iShares U.S. Healthcare ETF (IYH - Free Report) are also worth a look.
United Health (UNH - Free Report) , Johnson & Johnson (JNJ - Free Report) , AbbVie (ABBV), Pfizer (PFE - Free Report) and Eli Lilly (LLY - Free Report) are among the top holdings in these ETFs. To learn more, please watch the short video above.